JP2009515977A5 - - Google Patents

Download PDF

Info

Publication number
JP2009515977A5
JP2009515977A5 JP2008541285A JP2008541285A JP2009515977A5 JP 2009515977 A5 JP2009515977 A5 JP 2009515977A5 JP 2008541285 A JP2008541285 A JP 2008541285A JP 2008541285 A JP2008541285 A JP 2008541285A JP 2009515977 A5 JP2009515977 A5 JP 2009515977A5
Authority
JP
Japan
Prior art keywords
cells
cancer
pharmaceutical composition
composition according
extract
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008541285A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009515977A (ja
Filing date
Publication date
Priority claimed from US11/559,324 external-priority patent/US7700136B2/en
Application filed filed Critical
Publication of JP2009515977A publication Critical patent/JP2009515977A/ja
Publication of JP2009515977A5 publication Critical patent/JP2009515977A5/ja
Pending legal-status Critical Current

Links

JP2008541285A 2005-11-14 2006-11-14 癌の治療のためのＳｃｕｔｅｌｌａｒｉａｂａｒｂａｔａ抽出物 Pending JP2009515977A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US73662005P 2005-11-14 2005-11-14
US11/559,324 US7700136B2 (en) 2005-11-14 2006-11-13 Scutellaria barbata extract for the treatment of cancer
PCT/US2006/044224 WO2007059149A2 (en) 2005-11-14 2006-11-14 Scutellaria barbata extract for the treatment of cancer

Publications (2)

Publication Number Publication Date
JP2009515977A JP2009515977A (ja) 2009-04-16
JP2009515977A5 true JP2009515977A5 (enExample) 2010-01-14

Family

ID=38041130

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008541285A Pending JP2009515977A (ja) 2005-11-14 2006-11-14 癌の治療のためのＳｃｕｔｅｌｌａｒｉａｂａｒｂａｔａ抽出物

Country Status (7)

Country Link
US (2) US7700136B2 (enExample)
EP (1) EP1965819A4 (enExample)
JP (1) JP2009515977A (enExample)
AU (1) AU2006315459A1 (enExample)
CA (1) CA2629638A1 (enExample)
GB (2) GB2448249A (enExample)
WO (1) WO2007059149A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006065599A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
US7700136B2 (en) * 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
US20090042818A1 (en) * 2007-06-22 2009-02-12 Bionovo, Inc. Liquiritigenin and Derivatives as Selective Estrogen Receptor Beta Agonists
US20080319051A1 (en) * 2007-06-22 2008-12-25 Bionovo, Inc. Liquiritigenin and derivatives as selective estrogen receptor beta agonists
AU2008285325A1 (en) * 2007-08-08 2009-02-12 Bionovo, Inc. Extracts of Ligustrum lucidum and uses thereof
AU2008296076A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of Pueraria lobata Willd, Ohwi of the Leguminosae family and uses thereof
WO2009033025A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. Estrogenic extracts of asparagus conchinchinensis (lour.) merr of the liliaceae family and uses thereof
US20090068298A1 (en) * 2007-09-07 2009-03-12 Bionovo, Inc. ESTROGENIC EXTRACTS OF Astragalus membranaceus Fisch. Bge. Var. mongolicus Bge. of the Leguminosae Family AND USES THEREOF
AU2008296136A1 (en) * 2007-09-07 2009-03-12 Bionovo. Inc. Estrogenic extracts of Scuttelaria barbata D. Don of the Labiatae Family and uses thereof
US8512961B2 (en) * 2007-11-19 2013-08-20 Bionovo, Inc. Methods of detecting and treatment of cancers using Scutellaria barbata extract
WO2009070478A2 (en) * 2007-11-19 2009-06-04 Bionovo, Inc. A process of making purified extract of scutellaria barbata d. don
AU2008326431A1 (en) * 2007-11-19 2009-05-28 Bionovo, Inc. Scutellaria barbata extract and combinations for the treatment of cancer
US20090130101A1 (en) * 2007-11-19 2009-05-21 Bionovo, Inc. Anti-cancer therapy with an extract of scutellaria barbata
AU2009236339A1 (en) * 2008-04-14 2009-10-22 Bionovo, Inc. Calycosin and analogs thereof for the treatment of estrogen receptor beta-mediated diseases
JP2011519947A (ja) * 2008-05-06 2011-07-14 バイオノボ・インコーポレーテッド 膣および外陰の委縮を治療するために使用するエストロゲン様抽出物
US20090311349A1 (en) * 2008-06-05 2009-12-17 Bionovo, Inc., A Delaware Corporation Method of quantification of multiple bioactives from botanical compositions
US20090312437A1 (en) * 2008-06-06 2009-12-17 Bionovo, Inc., A Delaware Corporation Anthraquinones and Analogs from Rhuem palmatum for Treatment of Estrogen Receptor Beta-Mediated Conditions
EP2323641A4 (en) * 2008-06-13 2012-06-20 Bionovo Inc NYASOL AND ANALOGUE THEREOF FOR THE TREATMENT OF ESTROGEN RECEPTOR-BETA-MEDIATED ILLNESSES
US20100069480A1 (en) * 2008-09-03 2010-03-18 Bionovo, Inc. A Delaware Corporation Methods and compositions for the treatment of cancer
WO2010110993A2 (en) * 2009-03-24 2010-09-30 Bionovo, Inc. Methods and compositions for the treatment of cancer
WO2010129343A2 (en) * 2009-04-28 2010-11-11 Bionovo, Inc. Method of reducing fat accumulation and inducing weight loss
US8858953B2 (en) 2011-05-09 2014-10-14 Yu-Hwa Peter Sheng Herbal composition for treating cancer
CN103599237B (zh) * 2013-11-28 2015-06-03 姜永华 一种治疗瘀阻胃络型胃癌的中药及其制备方法
US9789153B2 (en) 2014-07-02 2017-10-17 Hsiu-Hsien Tsai Composition for preventing cancer and treating cancer and intensifying the effects of other anticancer drugs

Family Cites Families (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1175485A1 (ru) * 1983-12-21 1985-08-30 Киевский Ордена Трудового Красного Знамени Медицинский Институт Им.Акад.А.А.Богомольца Способ лечени гипертонической болезни (его варианты)
FR2616328B1 (fr) * 1987-06-12 1990-03-02 Moet Hennessy Rech Composition a base de phases lamellaires lipidiques hydratees ou de liposomes contenant un extrait de murier, ou au moins une flavone, en particulier une kuwanone et composition pharmaceutique, notamment dermatologique, a activite depigmentante, ou anti-inflammatoire, ou cosmetique, l'incorporant
JPH01175942A (ja) * 1987-12-28 1989-07-12 Sanyo Kokusaku Pulp Co Ltd 抗ウイルス性医薬用組成物
DK0500739T3 (da) * 1989-11-03 1997-04-14 Alexander S Sun Urtebehandling af malignitet
JPH0725761A (ja) * 1993-07-09 1995-01-27 Kureha Chem Ind Co Ltd 軟骨保護剤
US5874084A (en) * 1996-07-19 1999-02-23 Yng-Wong; Quing Non Using complex herbal formulations to treat hot flashes
AU746946B2 (en) * 1997-03-21 2002-05-09 Shiseido Company Ltd. Immunopotentiators
MC2441A1 (fr) * 1997-07-31 1998-03-11 Exsymol Sa Composition cosmétique utile notamment pour le blanchiment de la peau et agent inhibiteur de la mélanogénèse comprenant une telle composition cosmétique
KR20010031501A (ko) * 1997-10-31 2001-04-16 추후제출 5-알파 환원효소 활성을 조절하는 방법 및 조성물
US6294526B1 (en) * 1998-02-06 2001-09-25 Alps Pharmaceutical Ind. Co., Ltd. Use of flavone derivatives for induction of β-lactam-sensitivity of MRSA
FR2784294B1 (fr) * 1998-10-12 2000-11-17 Oreal Composition cosmetique et/ou dermatologique renfermant au moins un extrait de murier, au moins un extrait de scutellaire et au moins un derive d'acide salicylique
US6304825B1 (en) * 1999-01-19 2001-10-16 Xerox Corporation Rotary encoder error compensation system and method for photoreceptor surface motion sensing and control
FR2791573B1 (fr) * 1999-03-30 2003-04-11 Pf Medicament Utilisation d'un extrait de serenoa repens pour la fabrication d'un medicament destine au traitement du cancer de la prostate
JP2001122871A (ja) 1999-10-26 2001-05-08 Nippon Kayaku Co Ltd エストロゲン様作用薬剤
CN1294009A (zh) * 1999-10-28 2001-05-09 马金发 抗癌中药制剂及其置备方法
DE10031650A1 (de) * 2000-06-29 2002-01-17 Schwabe Willmar Gmbh & Co Verwendung von Extrakten aus Sophora flavescens oder Sophora subprostrata zur Prophylaxe und Therapie von Krankheitszuständen, die durch einen Mangel an Östrogenen oder durch andere hormonelle Dysregulationen verursacht werden
JP4693963B2 (ja) 2000-07-12 2011-06-01 丸善製薬株式会社 エストロゲン様作用剤、コラーゲン産生促進剤、及び線維芽細胞増殖剤
US6238707B1 (en) * 2000-10-11 2001-05-29 Zhang Chun Herbal hormone balance composition
CN1486190A (zh) * 2000-12-12 2004-03-31 ά����ķ���޹�˾ 包含分离自半枝莲活性级分的组合物及其使用方法
US6551627B1 (en) * 2001-05-03 2003-04-22 Holomed Pharmaceuticals, Ltd. Medicinal herbal compounds for the prevention and treatment of diabetes
US6855344B2 (en) * 2001-07-17 2005-02-15 Integrated Chinese Medicine Holdings, Ltd. Compositions and methods for prostate and kidney health and disorders, an herbal preparation
US6750248B2 (en) 2001-11-09 2004-06-15 National University Of Singapore Methods for preparing an estrogenic preparation and isolated estrogenic compounds from a plant and uses thereof
US20030165588A1 (en) * 2002-03-01 2003-09-04 Unigen Pharmaceuticals, Inc. Identification of free-B-ring flavonoids as potent COX-2 inhibitors
US20050032882A1 (en) * 2002-03-06 2005-02-10 Sophie Chen Botanical extract compositions and methods of use
JP2004155779A (ja) 2002-10-16 2004-06-03 Taisho Pharmaceut Co Ltd 更年期症の予防・治療用経口組成物
AU2002952453A0 (en) * 2002-11-01 2002-11-21 Novogen Research Pty Ltd Aminated isoflavonoid derivatives and uses thereof
JP4474518B2 (ja) * 2003-03-28 2010-06-09 学校法人日本大学 ２−ヒドロキシイソフラバノンデヒドラターゼをコードするポリヌクレオチドおよびその応用
US20070122501A1 (en) * 2003-06-27 2007-05-31 Hong Kong University Of Science And Technology Formulations containing astragalus extracts and uses thereof
JP5300195B2 (ja) * 2003-09-08 2013-09-25 ジェニオウス バイオメド インターナショナル インコーポレイテッド 癌治療のための植物性薬品抽出物の組成物
US20050196409A1 (en) * 2003-09-24 2005-09-08 James Dao Compositions of botanical extracts for treating malignancy-associated changes
US20070122492A1 (en) * 2004-11-18 2007-05-31 Stephen Behr Plant extracts and dermatological uses thereof
US20050208159A1 (en) * 2004-03-16 2005-09-22 Kang Kyung S Phytoestrogenic composition comprising an extract of chinese licorice root, liquiritin or isoliquiritin
CA2565721C (en) * 2004-05-06 2015-10-06 Bioresponse, L.L.C. Diindolymethane formulations for the treatment of leiomyomas
US20050260285A1 (en) * 2004-05-21 2005-11-24 Dimateeo-Leggio Giovina Healthy prostate formula
JP4939425B2 (ja) * 2004-11-05 2012-05-23 ジェノミック ヘルス， インコーポレイテッド 乳癌の治療反応の予後および予測の分子指標
WO2006062876A2 (en) * 2004-12-09 2006-06-15 Merck & Co., Inc. Estrogen receptor modulators
CA2588566A1 (en) * 2004-12-17 2006-06-22 Bionovo, Inc. Estrogenic extracts of morus alba and uses thereof
WO2006065599A1 (en) 2004-12-17 2006-06-22 Bionovo, Inc. Method of using extracts of epimedium species
US7482029B2 (en) * 2005-04-01 2009-01-27 Bionovo, Inc. Composition for treatment of menopause
CN100488524C (zh) 2005-06-06 2009-05-20 广东医学院 一种由黄芪和司坦唑醇组成的治疗骨质疏松症的药物制剂
AU2006259583A1 (en) * 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
CN1723989A (zh) 2005-07-08 2006-01-25 山东省中医药研究院 葛藤提取物、制备方法及用途
US7700136B2 (en) 2005-11-14 2010-04-20 Bionovo, Inc. Scutellaria barbata extract for the treatment of cancer
RS55630B1 (sr) * 2005-12-21 2017-06-30 Janssen Pharmaceutica Nv Triazolopiridazini kao modulatori tirozin kinaze
CN1840134A (zh) 2006-01-21 2006-10-04 端智 舒更颗粒

Similar Documents

Publication Publication Date Title
He et al. Current advances in coptidis rhizoma for gastrointestinal and other cancers
CN103417561B (zh) 芍药苷类化合物在制备抗肿瘤药物中的用途
JP2007505042A5 (enExample)
NZ593641A (en) Extended soluble ph20 polypeptides and uses thereof
FI3849534T3 (fi) Yhdistelmähoidot
FI2547205T3 (fi) Uusia menetelmiä syövän kantasolujen kohdentamiseksi
WO2010028187A3 (en) Methods and compositions for the treatment of cancer
RU2018137037A (ru) Антинеопластические комбинации, содержащие hki-272 и винорелбин
NZ599031A (en) A dosage form containing two or more active pharmaceutical ingredients in different physical forms
HRP20192168T1 (hr) Privremena zaštita normalnih stanica tijekom kemoterapije
RU2012110580A (ru) Способы скрининга in vivo
Tai et al. Antiproliferation activity of Devil's club (Oplopanax horridus) and anticancer agents on human pancreatic cancer multicellular spheroids
JP2011157399A5 (enExample)
EP3276004A3 (en) Methods for treating chronic kidney disease
WO2007062222A3 (en) Inhibition of cell proliferation
GB2448249A (en) Scutellaria barbata extract for the treatment of cancer
JP2009511482A5 (enExample)
WO2009002808A3 (en) Quinazolinone compounds and methods of use thereof
WO2007065010A3 (en) Anti-angiogenesis compounds
JP2008519767A5 (enExample)
JP2008524329A5 (enExample)
Sharma et al. The aqueous root extract of Withania somnifera ameliorates LPS-induced inflammatory changes in the in vitro cell-based and mice models of inflammation
JP2010528091A5 (enExample)
Tian et al. Nrf2 in human cancers: Biological significance and therapeutic potential
Lee et al. Cudraxanthone H induces growth inhibition and apoptosis in oral cancer cells via NF-κ B and PIN1 pathways